1980
DOI: 10.2165/00003495-198020030-00005
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Use of Medium Chain Triglycerides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
28
0

Year Published

1991
1991
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(28 citation statements)
references
References 3 publications
0
28
0
Order By: Relevance
“…The benefits derived through blending vegetable oils with RCNO for the non-coconut oil consumer were incorporation of the MCFA and improved oxidative stability, without imparting any coconut oil flavor/aroma to the blends. These blends might also show 13% of the fat not being deposited in the body (due to the presence of 20% of coconut oil) [2,3,[17][18][19].…”
Section: Fatty Acid Compositionmentioning
confidence: 99%
“…The benefits derived through blending vegetable oils with RCNO for the non-coconut oil consumer were incorporation of the MCFA and improved oxidative stability, without imparting any coconut oil flavor/aroma to the blends. These blends might also show 13% of the fat not being deposited in the body (due to the presence of 20% of coconut oil) [2,3,[17][18][19].…”
Section: Fatty Acid Compositionmentioning
confidence: 99%
“…From these observations, it is likely that colonic absorption of MCFAs may be responsible for a large part of the benefit seen with oral medium chain triacylglycerol (MCT) therapy to patients with compromised small bowel function. 20 The ability of the colon to absorb octanoate was directly demonstrated by measuring octanoate appearance in the mesenteric venous blood, along with its metabolites, over a wide concentration range ( fig 3A). This luminal substrate was available to the epithelial cells for oxidation to CO 2 and ketone bodies, and for other metabolic processes within the cell (table 1).…”
Section: Discussionmentioning
confidence: 99%
“…MCTs are in fact already used in a range of malabsorptive disorders, as substitution of medium chain for long chain triacylglycerols (LCT) has been shown to reduce fat excretion. 20 Although this reduction has been explained by a more rapid absorption of MCT than of LCT in the small bowel, 21 22 colonic absorption of MCFAs may have been a contributing factor. This view is supported by a study in short bowel patients where substitution of MCT for 50% of existing dietary LCT was done.…”
Section: Discussionmentioning
confidence: 99%
“…Specifically, our purpose was to determine the effects of our experimental conditions on the percentage of biliary acids, the interrelation between bile acids and bile lipids, and the lithogenic index. In addition, we studied whether the addition of exogenous bile acid (ursodeoxycholic acid) absorbed passively by the intestine (Ruppin & Midleton, 1980;Rutgeerts et al 1982;Sthiel, Raedesch & Rudolph, 1988) was partly able to compensate for the disruption of enterohepatic circulation.…”
Section: Introductionmentioning
confidence: 99%